Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Molecular Characterisation and Outcomes of 363 Adolescent and Young Adults with AML in Saudi Arabia Risk Stratified By PCR and NGS-Based Testing

Blood (2023) 142 (Supplement 1): 7433.

https://doi.org/10.1182/blood-2023-187940

Published: 2023

Journal Articles

Comparison between Automated Erythrocytopharesis (AECP) and Manual Exchange Transfusion (M-Ex)) in Reducing Hb-S and in Recovery of Acute Chest Syndrome and Other Acute Presentations of Sickle Cell Disease Patients

Said Yousuf Ahmed, MD, Sameh M. Saleh, MD, Mohamed Shefan Hameed, MD, Ahmed M. Ragheb, MD, Telal M. Abbas, MD, AbdelMunim Fadel, Siddiq Hassan, MD, Hussein S. Baden, MBBS, FRCP, FRCPath, Khaled I Tayeb, MD, Nasir Bakshi, MD, Ghaleb El Yamany, MBBS, FRCP, FRCPath, Sultan Bejad Alotaibi

Blood (2018) 132 (Supplement 1): 4928.

https://doi.org/10.1182/blood-2018-99-119785

Published: 2018

Journal Articles

Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): Clinical Features, Treatment, and Outcome. a Single Institution Result of 145 Patients from the Middle East

Saad Akhtar, MD, Amani Al-Kofide, MD, Nasir Bakshi, MD, Mohammed Shamayel, MD, Yasser Khafaga, MD, Suleimman Al-Sweedan, MD, Tusneem Elhassan, MSc, M S Rauf, MD, Irfan Maghfoor, MD

Blood (2017) 130 (Supplement 1): 2794.

https://doi.org/10.1182/blood.V130.Suppl_1.2794.2794

Published: 2017

Journal Articles

Monocytopenia Is Universally Present in Adults with Hemophagocytic Syndrome/Hemophagocytic Lymphohistiocytosis (HLH), Responds to Treatment, and Can be Used As a Sensitive Additional Diagnostic Criterion and As a Prognostic Marker

Said Yousuf Mohamed, MD, Muhamad Hitham Almahayni, MD MRCP, Wahiba Chebbo, Ahmed Shad, MRCP, MD, Abdul Mannan, Osama Abdelwahid, Maamoun AlSermani, MRCP, MD, Feras Alfraih, MD, Shaheen Marwan, MD, Majed Halim, MD, Nasir Bakshi, MD, Hazaa Alzahrany

Blood (2016) 128 (22): 1330.

https://doi.org/10.1182/blood.V128.22.1330.1330

Published: 2016

Journal Articles

CD64 Expression Is An Independent Adverse Prognostic Factor in Pediatric Acute Myeloid Leukemia Treated with Allogeneic Stem Cell Transplantation,

Maher Albitar, M.D., Amal Alseraihy, M.D., Mouhab Ayas, Abdullah Al-Jefri, M.D., Ali Al-Ahmari, MD, Asim F Belgaumi, MD, Claudia Ulrike Walter, PhD, Randa Nounou, M.D., Salem Khalil, M.D., Nasir Bakshi, M.D., Tarek Owaidah, MD, FRCPA, Hassan El-Solh, MD

Blood (2011) 118 (21): 3525.

https://doi.org/10.1182/blood.V118.21.3525.3525

Published: 2011

Journal Articles

Discrepancies in Serum Free Light Chain Assays and Immunofixation for Response Evaluation and Prognostication in Plasma Cell Proliferative Disorders

Nasir Bakshi, M.D., Nahlah AlGhasham, MD, Maha Alharbi, Jalaluddin Bhuiyan, Ph.D, Ghada Elgohary, MD, Fahad Alsharief, MD

Blood (2011) 118 (21): 5099.

https://doi.org/10.1182/blood.V118.21.5099.5099

Published: 2011

Journal Articles

CD34 Expression in Adult Acute Lymphoblastic Leukemia (ALL) Is a Favorable Prognostic Factor in Patients Treated with Stem Cell Transplant in First Remission,

Mahmoud Aljurf, M.D., Naeem A. Chaudhri, MD, FACP, Fahed Almhareb, MBBS, FACP, Claudia Ulrike Walter, PhD, Randa Nounou, M.D., Salem Khalil, M.D., Nasir Bakshi, M.D., Tarek Owaidah, MD, FRCPA, Hazzaa Al Zahrani, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Maher Albitar, M.D.

Blood (2011) 118 (21): 4091.

https://doi.org/10.1182/blood.V118.21.4091.4091

Published: 2011

Journal Articles

CD11b Expression Is An Independent Adverse Prognostic Factor in Pediatric Acute Myeloid Leukemia Treated with Allogeneic Stem Cell Transplantation,

Blood (2011) 118 (21): 4092.

https://doi.org/10.1182/blood.V118.21.4092.4092

Published: 2011

Journal Articles

Lack of CD34 Expression in Acute Myeloid Leukemia (AML) Is a Favorable Prognostic Factor in Patients Treated with Stem Cell Transplant Irrespective of the Cytogenetic Risk

Fahed Almhareb, MBBS, FACP, Claudia Ulrike Walter, PhD, Randa Nounou, M.D., Salem Khalil, M.D., Nasir Bakshi, M.D., Tarek Owaidah, MD, FRCPA, Naeem A. Chaudhri, MD, FACP, Hazzaa Al Zahrani, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.

Blood (2011) 118 (21): 1894.

https://doi.org/10.1182/blood.V118.21.1894.1894

Published: 2011

Journal Articles

FOXP3 Can Predict Disease Progression and Risk of Transformation in Uniformly Treated Patients with Mycosis Fungoides

Nasir Bakshi, M.D., Rami Albugami, MD, Abdulmonem Almutawa, MD, Mohammed Alghamdi, Irfan Maghfoor, MD, Saad Akhter, MD

Blood (2011) 118 (21): 5182.

https://doi.org/10.1182/blood.V118.21.5182.5182

Published: 2011

Journal Articles

Expression of CD56 in Acute Myeloid Leukemia (AML) Is Associated with Poor Outcome When Patients Treated with Stem Cell Transplant in Second Remission but Not in the First Remission

Naeem A. Chaudhri, MD, FACP, Fahed Almhareb, MBBS, FACP, Claudia Ulrike Walter, PhD, Randa Nounou, M.D., Salem Khalil, M.D., Nasir Bakshi, M.D., Tarek Owaidah, MD, FRCPA, Hazzaa Al Zahrani, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.

Blood (2011) 118 (21): 4880.

https://doi.org/10.1182/blood.V118.21.4880.4880

Published: 2011

Journal Articles

Dominance of Non-CLL Phenotype of Monoclonal B-Cell Lymphocytosis (MBL) in the Middle East and An Overall MBL Prevalence Comparable to Western Countries

Maher Albitar, M.D., Faisal Rawas, MT, Randa Nounou, M.D., Nasir Bakshi, M.D., Fahed Almhareb, M.D., Hazzaa Al Zahrani, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Salem Khalil, M.D., Fahad Alsharif, M.D., Naeem A. Chaudhri, MD, FACP, Hassan El-Solh, MD, Mahmoud Aljurf, M.D.

Blood (2011) 118 (21): 4586.

https://doi.org/10.1182/blood.V118.21.4586.4586

Published: 2011

Journal Articles

Tumor Microenvironment In Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) Influences Occurrence of Relapses and Progression to Large Cell Lymphoma

Nasir Bakshi, MD, Mansoor Aljabry, MD, Saad Akhter, Irfan Maghfoor, MD, Ayman Mashi

Blood (2010) 116 (21): 2684.

https://doi.org/10.1182/blood.V116.21.2684.2684

Published: 2010

NARROW

Molecular Characterisation and Outcomes of 363 Adolescent and Young Adults with AML in Saudi Arabia Risk Stratified By PCR and NGS-Based Testing

Comparison between Automated Erythrocytopharesis (AECP) and Manual Exchange Transfusion (M-Ex)) in Reducing Hb-S and in Recovery of Acute Chest Syndrome and Other Acute Presentations of Sickle Cell Disease Patients

Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL): Clinical Features, Treatment, and Outcome. a Single Institution Result of 145 Patients from the Middle East

Monocytopenia Is Universally Present in Adults with Hemophagocytic Syndrome/Hemophagocytic Lymphohistiocytosis (HLH), Responds to Treatment, and Can be Used As a Sensitive Additional Diagnostic Criterion and As a Prognostic Marker

CD64 Expression Is An Independent Adverse Prognostic Factor in Pediatric Acute Myeloid Leukemia Treated with Allogeneic Stem Cell Transplantation,

Discrepancies in Serum Free Light Chain Assays and Immunofixation for Response Evaluation and Prognostication in Plasma Cell Proliferative Disorders

CD34 Expression in Adult Acute Lymphoblastic Leukemia (ALL) Is a Favorable Prognostic Factor in Patients Treated with Stem Cell Transplant in First Remission,

CD11b Expression Is An Independent Adverse Prognostic Factor in Pediatric Acute Myeloid Leukemia Treated with Allogeneic Stem Cell Transplantation,

Lack of CD34 Expression in Acute Myeloid Leukemia (AML) Is a Favorable Prognostic Factor in Patients Treated with Stem Cell Transplant Irrespective of the Cytogenetic Risk

FOXP3 Can Predict Disease Progression and Risk of Transformation in Uniformly Treated Patients with Mycosis Fungoides

Expression of CD56 in Acute Myeloid Leukemia (AML) Is Associated with Poor Outcome When Patients Treated with Stem Cell Transplant in Second Remission but Not in the First Remission

Dominance of Non-CLL Phenotype of Monoclonal B-Cell Lymphocytosis (MBL) in the Middle East and An Overall MBL Prevalence Comparable to Western Countries

Tumor Microenvironment In Nodular Lymphocyte Predominant Hodgkin Lymphoma (NLPHL) Influences Occurrence of Relapses and Progression to Large Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only